Digital Medical Hub

What Digital Medical Hub does

Digital Medical Hub (DMH) is a Paris-based health innovation consulting firm that was spun out of AP-HP's Direction de la Recherche Clinique et de l'Innovation in 2021 to commercialize clinical evaluation methodologies developed by AP-HP clinicians since 2018. The firm offers an integrated 360-degree service portfolio spanning market access strategy, clinical research and trial execution, regulatory affairs and quality management (including CE marking and PECAN/HAS reimbursement dossiers), and medical device co-development. Its stated clients are digital health startups, medtech manufacturers, pharmaceutical companies and hospital institutions, supported through offices in Paris, Lyon, Nice and Bordeaux and a network of 40+ hospital structures and hundreds of clinical investigators across multiple specialties.

The firm's core technology asset is e-Health Guardian, an AI-positioned platform that evaluates the compliance of digital health solutions against current regulatory frameworks and supports product/regulatory alignment. DMH also operates DMH Académique, a loi 1901 association that conducts independent clinical research, publishes indexed scientific studies and animates a national investigator network. The 360-degree methodology combines AI/GDPR, clinical, regulatory, cybersecurity, UX, public health and CSR dimensions, and is delivered by 29 staff organized across a Medical Committee (4), Management Committee (7) and Operational team (18), including BPI-labeled experts. Strategic partnerships with MedInTechs (under presidential patronage), French Tech HIIT, Hello Tomorrow/Biolabs EU, the France 2030 tiers-lieux network and academic institutions (INRIA, CNRS, Aix-Marseille Université, Mines ParisTech) extend DMH's reach across the French and European health innovation ecosystem.

DMH generates revenue through project-based professional services engagements across its four service lines (market access, clinical research, regulatory/quality, and co-development), with pricing bespoke to each engagement and not publicly disclosed. The firm claims to have supported 200+ projects and 100+ clinical experiments/trials, and to have helped clients raise approximately €72M per year on average, alongside €11.5M of research project value. The company is institutionally affiliated with AP-HP (parent/origin entity), operates under the contact domain dmh-aphp.fr, and has no disclosed external venture or private equity investors.

Name

Digital Medical Hub

Legal name

Digital Medical Hub

Website

https://digitalmedicalhub.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

Digital Medical Hub is a Paris-headquartered health innovation consultancy spun out of AP-HP in 2021, providing 360-degree market access, clinical research, regulatory and co-development services to digital health startups, medtech manufacturers, pharmaceutical firms and hospital institutions across France and Europe.

Ownership category

akta.pro rank

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Professional Services - Market Access: Fee-for-service consulting engagements for startups and medtech companies seeking market access strategy, reimbursement dossier preparation (PECAN, HAS), and pricing negotiations with health authorities. Revenue is project-based, typically multi-phase engagements from early clinical strategy through to market launch.
2. Professional Services - Clinical Research: Engagements covering clinical study design, protocol writing, regulatory submissions, investigator network management, and clinical data analysis. Services are tailored to both pre-market and post-market clinical investigation needs of digital medical device companies.
3. Professional Services - Regulatory Affairs & Quality: Quality management system structuring, CE marking dossier preparation, regulatory strategy, and compliance audits. Also includes immersive workshops and team training on quality system requirements.
4. Professional Services - Product Co-development: Joint product development engagements including desirability and feasibility studies, technical roadmap definition, functional and technical specifications, UX design, and clinical integration strategy, from concept through market-ready product.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

Core offering

Digital Medical Hub provides 360-degree consulting and evaluation services for digital health innovations and medical devices, integrating market access strategy, clinical research, regulatory affairs and quality systems, and medical device co-development. The firm operates the proprietary e-Health Guardian AI platform for regulatory compliance evaluation and coordinates a national network of 40+ hospital structures and clinical investigators across specialties (geriatrics, gynecology, pediatrics, mental health, paramedical, emergency, ICU, cardiology, dentistry). Engagements span from early clinical strategy through CE marking, HAS reimbursement pathway preparation, and market launch for healthtech startups, medtech companies, and healthcare institutions.

Product overview

Digital Medical Hub (DMH) is a health innovation acceleration ecosystem and service platform, functioning as a spin-off from AP-HP (Assistance Publique - Hôpitaux de Paris). The platform offers an integrated 360-degree service portfolio combining Market Access strategy, Clinical Research, Regulatory Affairs & Quality, and Medical Device Co-development. The core AI-powered platform is e-Health Guardian, which provides compliance evaluation for digital health solutions. DMH also operates a national clinical research network of healthcare professionals and manages experimentation third-places for real-world testing. The offering is structured around expert poles collaborating across 40+ hospital structures to support over 200 health and digital health projects.

Differentiator

Problem solved

Functional benefit

Brands

• e-Health Guardian: AI platform that evaluates the compliance of digital health solutions according to applicable frameworks to ensure development aligned with regulatory requirements.
• DMH Académique

Products and services

• e-Health Guardian Proprietary AI platform that evaluates the compliance of digital health solutions according to current regulatory standards and referentials, ensuring product development is aligned with regulatory requirements. Supports the 360-Degree Project Diagnostic across AI, GDPR, clinical, interoperability, cybersecurity, UX, public health, and RSE dimensions.
• Market Access Services Strategic market access consulting for digital health startups and medtech companies, covering pricing and reimbursement pathway development, medico-economic studies, hospital tariff analysis, health data valorization, PECAN and HAS dossier preparation, and engagement with mutual and health insurance providers.
• Clinical Research Services Comprehensive clinical investigation methodology and trial execution for digital medical devices, including scientific framing, study design, statistical analysis planning, regulatory submissions, investigator center identification, data analysis, and scientific publication. Covers both pre-market and post-market clinical investigation needs.
• Regulatory Affairs and Quality Services Quality management system structuring and regulatory affairs support for CE marking of digital medical devices, including regulatory strategy, CE dossier preparation, compliance audits with quality requirements, and immersive workshops and team training on quality system requirements.
• Medical Device Co-development Services
• Clinical Research Network National clinical research network of investigators including hospital physicians, academics, liberal professionals, and paramedical staff (nurses, physiotherapists, occupational therapists) for conducting real-world digital health studies on behalf of DMH's startup, medtech, and pharmaceutical clients.
• Experimentation Third-Places (Tiers-Lieux) Real-life experimentation infrastructure operated in partnership with healthcare organizations under the France 2030 digital health acceleration strategy, providing methodological support, market access expertise, and regulatory guidance for healthtech startups conducting real-world studies.

Quantifiable outcome

• 200+ projects supported in under 4 years of operation
• +6 more outcomes

Named customers19 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Eight partnerships are on record, tiered core, flagship and minor.

• AP-HP (Assistance Publique – Hôpitaux de Paris)coreStrategic or Co-development Partner · 1 January 2021DMH originated as a spin-off of AP-HP's Direction of Clinical Research and Innovation (DRCI) in 2021. AP-HP is the largest hospital system in Europe. This founding relationship provides DMH with privileged access to hospital structures, clinical investigators, and institutional networks that form the backbone of DMH's service delivery ecosystem.
• MedInTechsflagshipStrategic or Co-development PartnerMedInTechs is a major health innovation program operating under the High Patronage of the President of France, Emmanuel Macron. DMH is a partner in the MedInTechs program, which positions DMH as a key expert and facilitator within France's national health innovation ecosystem. The partnership connects DMH with institutional, industrial, and governmental stakeholders across the French health sector.
• French TechcoreStrategic or Co-development PartnerDMH partners with French Tech on the HIIT (Health Innovation Intensive Training) acceleration program. French Tech is France's national startup ecosystem initiative. The partnership enables DMH to reach and support early-stage healthtech startups, providing clinical and regulatory expertise as part of French Tech's acceleration services.
• Hello Tomorrow & BiolabscoreStrategic or Co-development PartnerDMH participates in the EU Start-up Program jointly run by Hello Tomorrow (a global deeptech innovation organization) and Biolabs (an international life sciences coworking and lab network). Through this program, DMH provides mentorship and expert guidance to European healthtech startups, expanding its reach across the continent.
• Onco-AtlantiquecoreStrategic or Co-development PartnerOnco-Atlantique is a tiers-lieu d'expérimentation (real-world experimentation hub) focused on accelerating digital oncology innovations. DMH is a founding partner alongside Institut de Cancérologie de l'Ouest, Institut Bergonié, and Centre Hospitalier Mont de Marsan. DMH contributes expertise in market access and regulatory affairs, helping de-risk digital health solutions for cancer care and secure reimbursement and deployment.
• RICH (Recherche et Innovation en Cancérologie)minorStrategic or Co-development PartnerRICH is a clinical research network that regularly collaborates with DMH on projects. DMH leverages RICH's investigator network and research infrastructure to conduct clinical studies, while contributing methodological expertise and regulatory guidance to consortium projects.
• Unirein, OceanCare, Genopôle, DigimentallyminorStrategic or Co-development PartnerDMH has partnered with multiple tiers-lieux d'expérimentation (real-world experimentation hubs) across France, aligned with the France 2030 Digital Health acceleration strategy. These include Unirein, OceanCare, Genopôle, and Digimentally. Each partnership provides DMH with access to specific patient populations, medical specialties, and experimentation infrastructure, while DMH contributes its 360-degree methodology for evaluating and supporting digital health projects.
• INRIA, CNRS, Aix-Marseille Université, Mines ParisTech, AP-HPminorStrategic or Co-development PartnerThese academic and research institutions participate in the RHU REBONE consortium alongside DMH. The project is financed by ANR under France 2030. DMH's role within the consortium includes project management, market access strategy, and clinical study support, while academic partners contribute fundamental research capabilities and clinical site access.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Wavestone: Wavestone is a French consulting firm with a significant healthcare and life sciences practice serving pharma, medtech, and hospital clients across regulatory, market access, and digital transformation. It is comparable to DMH as a French consulting peer addressing similar healthcare client needs with overlapping service lines.
• Alira Health: Alira Health is a global healthcare and life sciences consulting firm supporting medical device, digital health, and pharma clients with clinical research, regulatory affairs, market access, and product development. It is directly comparable to DMH's 360-degree service model targeting the same digital health and medtech client base.
• NAMSA: NAMSA is a medical device-focused CRO and consulting firm offering regulatory, clinical, and quality services to medical device manufacturers globally. It is comparable to DMH as both serve medtech companies navigating CE marking, clinical investigation, and market access with full-stack service portfolios.
• Alcimed: Alcimed is a French innovation and strategy consulting firm with dedicated healthcare and life sciences practices serving pharma, medtech, and public-sector clients. It is comparable to DMH as a domestic French peer serving similar digital health and medical device clients with strategy, market access, and innovation support services.

Broad incumbents

• ZS Associates: ZS Associates is a global consulting firm with a major healthcare and life sciences practice advising pharma, medtech, and digital health clients on strategy, market access, and commercial operations. It is comparable to DMH as a broader incumbent offering overlapping market access and strategy services in digital health.
• ICON plc: ICON plc is a global CRO providing clinical research, regulatory, and consulting services to pharma, biotech, and medical device clients. It is comparable to DMH as a broad incumbent offering clinical trial execution and regulatory affairs services overlapping with DMH's clinical research practice.
• McKinsey & Company: McKinsey's Healthcare Practice advises pharma, medtech, and digital health clients globally on strategy, market access, and innovation. It is comparable to DMH as a broader incumbent offering high-level strategy and digital health advisory work that overlaps with DMH's market access and product co-development services.
• Bain & Company: Bain & Company operates a global Healthcare practice advising pharma, medtech, and digital health clients on commercial strategy, market access, and innovation. It is comparable to DMH as a broader incumbent offering overlapping digital health and medical device strategy advisory services.
• Charles River Laboratories: Charles River Laboratories is a global CRO and preclinical/clinical research services provider serving pharma, biotech, and medical device manufacturers. It is comparable to DMH as a broad incumbent offering clinical research and regulatory services overlapping with DMH's clinical and regulatory affairs practice.
• IQVIA: IQVIA is a global clinical research services, healthcare data, and consulting provider serving pharma, biotech, and medtech clients across the full development and commercialization lifecycle. It is comparable to DMH as a broad incumbent providing overlapping clinical research, regulatory, and market access services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/dmh75

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Digital Medical Hub